Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

BACKGROUND: The objective of this study was to evaluate trends in survival and health care costs in metastatic melanoma in the era of targeted and immunotherapeutic drugs. MATERIALS AND METHODS: Data on survival and health care resource use were retrieved from the Dutch Melanoma Treatment Registry....

Descripción completa

Detalles Bibliográficos
Autores principales: Franken, M.G., Leeneman, B., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., van den Eertwegh, A.J.M., de Groot, J.W.B., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R.S., Suijkerbuijk, K.P.M., van der Veldt, A.A.M., Westgeest, H.M., Wouters, M.W.J.M., Haanen, J.B.A.G., Uyl-de Groot, C.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639434/
https://www.ncbi.nlm.nih.gov/pubmed/34856511
http://dx.doi.org/10.1016/j.esmoop.2021.100320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639434/
https://www.ncbi.nlm.nih.gov/pubmed/34856511
http://dx.doi.org/10.1016/j.esmoop.2021.100320

Ejemplares similares